Emily Lutterloh, M.D., MPH

SUNY Assistant Professor
Department of Epidemiology and Biostatistics

NYS Department of Health
Director, Bureau of Healthcare Associated Infections

Corning Tower, Room 523
Empire State Plaza
Albany, NY 12237

Phone: 518-474-1142
Fax: 518-402-5165

E-mail: emily.lutterloh@health.ny.gov

1994–1998   MD ; Indiana University School of Medicine, Indianapolis, IN
2008–2010   MPH;  Johns Hopkins Bloomberg School of Public Health

Research Interests:
Healthcare associated infections

Guest lecturer, Infectious Disease Epidemiology course

Selected Publications and Presentations:
1. Lutterloh EC, Opal S, Pittman DD, et al. Inhibition of the receptor for advanced glycation end products (RAGE) increases survival in experimental models of severe sepsis and systemic infection. Crit Care. 2007;11(6):R122.

2. Lutterloh EC, Iqbal S, Clower JH, Spiller HA, Riggs MA, Sugg TJ, Humbaugh KE, Cadwell BL, Thoroughman DA. Carbon monoxide poisoning after an ice storm in Kentucky, 2009. Public Health Rep. 2011;126(S1):108–15.

3. Lutterloh E, Likaka A, Sejvar J, et al. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis. 2012;54:1100–6.

4. Sejvar J, Lutterloh E, Naiene J, et al. Neurologic manifestations associated with an outbreak of typhoid fever, Malawi-Mozambique, 2009: an epidemiologic investigation. PloS One. 2012;7:e46099. doi: 10.1371/journal.pone.0046099. Epub 2012 Dec 3.

5. Lutterloh EC, Birkhead G. Surveillance of health care-associated infections: challenges and opportunities. J Public Health Manag Pract. 2013;19:286–8.

6. Haley VB, DiRienzo AG, Lutterloh EC, Stricof RL. Quantifying sources of bias in National Healthcare Safety Network laboratory-identified Clostridium difficile infection rates. Infect Control and Hosp Epidem. 2014;35:1–7.

7. Hazamy PA, Haley VB, Tserenpuntsag B, Tsivitis M, Giardina R, Knab R, Lutterloh E. Effect of 2013 National Healthcare Safety Network definition changes on central line bloodstream infection rates: audit results from the New York State Department of Health. Am J Infect Control. 2015;43:280–2.

8. Wise ME, Bancroft E, Clement EJ, Hathaway S, High P, Kim M, Lutterloh E, et al. Infection prevention and control in the podiatric medical setting. Challenges to providing consistently safe care. J Am Podiatr Med Assoc. 2015;105:264–72.

9. Robyn MP, Hunter JC, Burns A, Newman AP, White J, Clement EJ, Lutterloh E, et al. Notes from the field: adverse events associated with administration of simulation intravenous fluids to patients — United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:226–7.

10. Lee EH, Adams EH, Madison-Antenucci S, Lee L, Barnwell JW, Whitehouse J, Clement E, Bajwa W, Jones LE, Lutterloh E, Weiss D, Ackelsberg J. Healthcare-associated transmission of Plasmodium falciparum in New York City. Infect Control and Hosp Epidem. 2016;37:113–5.